EGFR mutations and molecularly targeted therapy: a new era in the treatment of lung cancer

Nat Clin Pract Oncol. 2006 Apr;3(4):170-1. doi: 10.1038/ncponc0476.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Carcinoma, Non-Small-Cell Lung / genetics*
  • Clinical Trials as Topic
  • Drug Delivery Systems
  • ErbB Receptors / antagonists & inhibitors*
  • ErbB Receptors / biosynthesis
  • ErbB Receptors / genetics
  • Erlotinib Hydrochloride
  • Gefitinib
  • Gene Dosage
  • Genes, erbB-1*
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / genetics*
  • Mutation*
  • Protein Kinase Inhibitors / therapeutic use
  • Quinazolines / therapeutic use

Substances

  • Protein Kinase Inhibitors
  • Quinazolines
  • Erlotinib Hydrochloride
  • ErbB Receptors
  • Gefitinib